Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.950
-0.050 (-1.25%)
At close: Feb 12, 2026

PEX:BPC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
46.5740.6543.1347.0345.4735.85
Revenue Growth (YoY)
22.60%-5.74%-8.31%3.44%26.82%3.70%
Cost of Revenue
31.2327.4628.1630.1328.1422.42
Gross Profit
15.3313.1914.9716.9117.3313.43
Selling, General & Admin
6.185.556.947.136.846.28
Operating Expenses
6.395.557.797.357.016.55
Operating Income
8.947.647.189.5610.316.88
Interest Expense
-0.06-0.03-0.09-0.11-0.2-0.24
Interest & Investment Income
0.040.04----
Currency Exchange Gain (Loss)
3.75-0.27-0.34-1.910.050.23
Other Non Operating Income (Expenses)
-0.010.10.260.120.090.07
EBT Excluding Unusual Items
12.677.4877.6710.266.94
Gain (Loss) on Sale of Investments
1.06-1.43-0.062.052.691.33
Gain (Loss) on Sale of Assets
--0.05-0.16-
Asset Writedown
----0.690.27-
Other Unusual Items
------0.12
Pretax Income
13.736.0679.0213.388.15
Income Tax Expense
0.990.870.851.091.210.78
Earnings From Continuing Operations
12.745.196.157.9312.177.38
Minority Interest in Earnings
0.09-0-0.040.01-0.09-0.01
Net Income
12.835.186.127.9512.087.37
Net Income to Common
12.835.186.127.9512.087.37
Net Income Growth
258.69%-15.26%-23.05%-34.21%63.91%-22.63%
Shares Outstanding (Basic)
393939383939
Shares Outstanding (Diluted)
393939383939
Shares Change (YoY)
--2.30%-2.38%--
EPS (Basic)
0.330.130.160.210.310.19
EPS (Diluted)
0.330.130.160.210.310.19
EPS Growth
258.69%-15.26%-24.77%-32.60%63.91%-22.63%
Free Cash Flow
2.085.438.831.622.725.13
Free Cash Flow Per Share
0.050.140.230.040.070.13
Dividend Per Share
0.0500.0500.0500.1000.0500.073
Dividend Growth
---50.00%100.00%-31.97%-31.82%
Gross Margin
32.93%32.45%34.71%35.94%38.11%37.46%
Operating Margin
19.21%18.80%16.65%20.32%22.68%19.19%
Profit Margin
27.56%12.75%14.18%16.90%26.56%20.55%
Free Cash Flow Margin
4.46%13.37%20.47%3.44%5.98%14.30%
EBITDA
10.359.068.6811.2211.988.57
EBITDA Margin
22.23%22.28%20.12%23.85%26.34%23.89%
D&A For EBITDA
1.411.421.51.661.661.69
EBIT
8.947.647.189.5610.316.88
EBIT Margin
19.21%18.80%16.65%20.32%22.68%19.19%
Effective Tax Rate
7.19%14.35%12.09%12.07%9.05%9.51%
Advertising Expenses
-1.151.28-0.110.07
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.